Century Therapeutics Inc.

NASDAQ: IPSC · Real-Time Price · USD
0.56
0.01 (1.82%)
At close: Aug 15, 2025, 3:59 PM
0.58
3.17%
After-hours: Aug 15, 2025, 05:56 PM EDT

Century Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
76.56M -36.07M -31.22M -31.21M -28.06M -39.4M -32.72M -33.29M -31.26M -31.68M -30.75M -30.99M -37.51M -28.19M -26.01M -23.27M -18.35M
Depreciation & Amortization
3.22M 3.32M 3.3M 3.46M 3.23M 3.55M 3.35M 3.23M 2.91M 2.84M 2.77M 1.67M 1.16M 1.05M 1.04M 935K 718K
Stock-Based Compensation
2.43M 2.66M 3.32M 3.5M 3.21M 3.56M 3.98M 3.29M 3.8M 2.73M 2.79M 2.77M 2.38M 1.64M 1.22M 1.71M 95K
Other Working Capital
n/a 1.35M -2.02M 2.59M -9.73M -24K 8.19M 4.6M -1.02M 4.22M -294K 2.84M 121.97M -1.47M 55K 473K -11K
Other Non-Cash Items
n/a 4.04M -949K 8.5M 9.4M 22.52M -437K -787K -682K 614K 538K 514K 264K 330K 285K 289K 305K
Deferred Income Tax
n/a 870K n/a n/a n/a -13.55M n/a 4.22M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
n/a 1.83M -2.77M 713K -9.05M -2.91M 12.18M 4.09M -3.98M 2.59M 412K 480K 120.46M 826K -523K 1.85M -4.95M
Operating Cash Flow
-34.62M -24.22M -28.33M -27.33M -30.25M -26.23M -13.65M -19.25M -29.22M -22.91M -24.24M -25.55M 86.75M -24.35M -23.98M -18.49M -22.18M
Capital Expenditures
n/a n/a 804K -265K -539K -980K -3.27M -4.5M -4.99M -6.27M -9.81M -10.46M -4.07M -16.72M -15.74M -10.63M -1.88M
Cash Acquisitions
n/a n/a n/a -9.61M n/a 92.15M -7.48M -11.47M -73.19M -238.22M -32.48M -22.98M -55.23M -30.34M n/a n/a n/a
Purchase of Investments
n/a -17.4M -13.2M -53.86M -35.09M -9.69M -57.5M -99.01M -42.83M -50.34M -66.38M -34.22M -103.06M -41.89M -146.08M -17.22M -124.85M
Sales Maturities Of Investments
-14.88M 48.18M 51.57M 29.87M 47.17M 29.27M 64.98M 110.49M 79.16M 52.33M 98.86M 57.2M 63.09M 38.01M 14.76M 16.2M 7.7M
Other Investing Acitivies
42.81M -175K 21K -23.99M 12.08M 19.58M 7.48M 11.47M 73.19M 238.22M 32.48M 22.98M 55.23M 30.34M -131.32M -1.02M -117.15M
Investing Cash Flow
27.93M 30.61M 39.2M -33.86M 11.54M 18.6M 4.22M 6.97M 31.34M -4.27M 22.66M 12.52M -44.04M -20.6M -147.05M -11.65M -119.03M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a -17.83M n/a n/a n/a n/a n/a -10.24M n/a n/a n/a n/a n/a 23K 1K 2.7M 33.81M
Financial Cash Flow
120K -602K 273K 56.7M 18.2M -356K 300K -10.12M 448K 95K 138K 47K 26.88M 106K -466K 224.65M 193.49M
Net Cash Flow
-6.57M 5.78M 13.97M -5.36M -512K -7.98M -9.13M -22.39M 2.57M -27.09M -1.44M -12.99M 69.59M -44.85M -171.5M 194.51M 52.27M
Free Cash Flow
-34.62M -24.38M -27.53M -27.6M -30.79M -27.21M -16.91M -23.75M -34.21M -29.18M -34.05M -36.01M 82.69M -41.07M -39.72M -29.12M -24.06M